0001315406-14-000088.txt : 20141112 0001315406-14-000088.hdr.sgml : 20141111 20141112163301 ACCESSION NUMBER: 0001315406-14-000088 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20141111 FILED AS OF DATE: 20141112 DATE AS OF CHANGE: 20141112 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIO RAD LABORATORIES INC CENTRAL INDEX KEY: 0000012208 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 941381833 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1000 ALFRED NOBEL DR CITY: HERCULES STATE: CA ZIP: 94547 BUSINESS PHONE: 5107247000 MAIL ADDRESS: STREET 1: 1000 ALFRED NOBEL DR CITY: HERCULES STATE: CA ZIP: 94547 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: STARK JAMES R CENTRAL INDEX KEY: 0001248083 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-07928 FILM NUMBER: 141214523 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2014-11-11 0000012208 BIO RAD LABORATORIES INC BIO, BIOB 0001248083 STARK JAMES R C/O BIO-RAD LABORATORIES, INC. 1000 ALFRED NOBEL DRIVE HERCULES CA 94547 0 1 0 0 VP, Corporate Controller Bio-Rad A Common Stock 2014-11-11 4 M 0 300 62.47 A 4257 D Bio-Rad A Common Stock 2014-11-11 4 S 0 300 112.23 D 3957 D Bio-Rad A Common Stock 2014-11-11 4 S 0 3357 112.56 D 600 D Bio-Rad A Common Stock 2014-11-11 4 S 0 600 113.04 D 0 D Non-Qualified Stock Option (right to buy) 62.47 2014-11-11 4 M 0 300 0 D 2016-04-03 Bio-Rad A Common Stock 300 0 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.86 to $112.83, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securites and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $112.94 to $113.09, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securites and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The option vested in five equal annual installments beginning on April 3, 2007. James R. Stark 2014-11-12